Medical Pharmaceutical Supply – Thrombin (Topical Hemostatic Agent)

The contract is for the supply of five vials of thrombin, a sterile topical hemostatic agent essential for controlling bleeding during surgical procedures. The product must meet stringent regulatory standards including FDA, USP, and Department of Defense specifications to ensure safety, efficacy, and compliance with military medical requirements. It is classified under NAICS code 325412, indicating it pertains to pharmaceutical and medicine manufacturing. The contract is structured as a subcontract under the Defense Logistics Agency, which operates under the Department of Defense, and is managed through the DIBBS platform with award reference SPE2D926F8026. The posting date indicates the opportunity was made available in August 2026, and while the place of performance and point of contact details are unspecified, the requirement implies delivery to a U.S. defense medical facility or logistics hub. All units must be sterile, properly labeled, and packaged to maintain integrity through handling and storage in operational environments.